Your browser doesn't support javascript.
loading
Correction: Real­world experience with calcitonin gene­related peptide­targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers.
Shibata, Mamoru; Fujita, Kazuki; Hoshino, Eri; Minami, Kazushi; Koizumi, Kenzo; Okada, Satoshi; Sakai, Fumihiko.
Affiliation
  • Shibata M; Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5­11­13 Sugano, Ichikawa, Chiba, 272­8513, Japan. mshibata@tdc.ac.jp.
  • Fujita K; Saitama International Headache Center, Saitama Neuropsychiatric Institute, Saitama, Japan.
  • Hoshino E; Saitama International Headache Center, Saitama Neuropsychiatric Institute, Saitama, Japan.
  • Minami K; Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5­11­13 Sugano, Ichikawa, Chiba, 272­8513, Japan.
  • Koizumi K; Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5­11­13 Sugano, Ichikawa, Chiba, 272­8513, Japan.
  • Okada S; Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5­11­13 Sugano, Ichikawa, Chiba, 272­8513, Japan.
  • Sakai F; Saitama International Headache Center, Saitama, Japan.
BMC Neurol ; 24(1): 157, 2024 May 09.
Article in En | MEDLINE | ID: mdl-38724927
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Japan